Spinal cord injury microenvironment

The spinal cord injury microenvironment describes the dynamic interplay of cellular entities (neurons, glia, immune cells), extracellular matrix components, cytokines, chemokines, ions, and bioactive molecules at the site of SCI. Following injury, the microenvironment becomes disrupted—characterized by increased inhibitory factors (e.g., reactive glial scarring, inflammatory mediators), decreased regenerative/promoting factors (e.g., neurotrophic support), immune cell infiltration and dysregulation, imbalance in cellular metabolic activities, demyelination, and axonal degeneration. These pathological changes impede neurological recovery and functional regeneration. Modifying the microenvironment using drugs, biomaterials, miRNAs, immune modulation, and other strategies is a major research focus, but no single molecule or receptor defines this target. Because the "spinal cord injury microenvironment" lacks the specificity required for structured molecular targeting (such as receptor, enzyme, ion channel, etc.), it should not be considered a canonical therapeutic target. Rather, it is an umbrella term—a pathological environment—that includes many molecular targets and therapeutic approaches.

Other names

SCI microenvironmentspinal cord lesion microenvironmentpost-injury microenvironment

Modulation of inflammation (anti-inflammatory); Promotion of regeneration (enhancing neurogenesis, axonal growth, myelin formation); Regulation of immune cell polarization (M1→M2 shift for microglia/macrophages); Inhibition of scar formation; Reduction of cell death (apoptosis/necrosis); Modulation of ECM composition